CRH plc
CRH plc (CRHCF) Financial Performance & Income Statement Overview
Review CRH plc (CRHCF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
CRH plc (CRHCF) Income Statement & Financial Overview
Review CRH plc CRHCF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $8.87B | $9.65B | $6.53B | $9.41B |
| Cost of Revenue | $5.71B | $5.98B | $4.73B | $6.03B |
| Gross Profit | $3.16B | $3.67B | $1.81B | $3.37B |
| Gross Profit Ratio | $0.36 | $0.38 | $0.28 | $0.36 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.93B | $1.95B | $1.79B | $2.04B |
| Operating Expenses | $2.06B | $1.85B | $1.79B | $2.04B |
| Total Costs & Expenses | $7.77B | $7.83B | $6.51B | $8.08B |
| Interest Income | $31.00M | $36.00M | $43.00M | $65.00M |
| Interest Expense | $160.00M | $155.00M | $133.00M | $144.00M |
| Depreciation & Amortization | $510.00M | $424.00M | $397.00M | $963.00M |
| EBITDA | $1.66B | $2.31B | $621.00M | $1.29B |
| EBITDA Ratio | $0.19 | $0.24 | $0.10 | $0.19 |
| Operating Income | $1.10B | $1.83B | $28.00M | $1.33B |
| Operating Income Ratio | $0.12 | $0.19 | $0.004 | $0.14 |
| Other Income/Expenses (Net) | -$117.00M | -$96.00M | $71.00M | -$28.00M |
| Income Before Tax | $987.00M | $1.73B | $99.00M | $1.23B |
| Income Before Tax Ratio | $0.11 | $0.18 | $0.02 | $0.13 |
| Income Tax Expense | $143.00M | $430.00M | -$19.00M | $304.50M |
| Net Income | $699.00M | $1.30B | $116.00M | $981.00M |
| Net Income Ratio | $0.08 | $0.13 | $0.02 | $0.10 |
| EPS | $1.03 | $1.89 | $0.16 | $1.37 |
| Diluted EPS | $1.02 | $1.88 | $0.16 | $1.37 |
| Weighted Avg Shares Outstanding | $678.40M | $685.50M | $687.80M | $715.31M |
| Weighted Avg Shares Outstanding (Diluted) | $683.70M | $688.80M | $693.40M | $715.31M |
The company's financials show resilient growth, with revenue advancing from $9.41B in Q4 2023 to $8.87B in Q4 2024. Gross profit remained healthy with margins at 36% in Q4 2024 compared to 36% in Q4 2023. Operating income hit $1.10B last quarter, sustaining a consistent 12% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.66B. Net income dropped to $699.00M, while earnings per share reached $1.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan